275 related articles for article (PubMed ID: 21592678)
1. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.
Eisbruch A; Kim HM; Feng FY; Lyden TH; Haxer MJ; Feng M; Worden FP; Bradford CR; Prince ME; Moyer JS; Wolf GT; Chepeha DB; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e93-9. PubMed ID: 21592678
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Worden FP; Feng M; Moyer JS; Prince ME; Carey TE; Wolf GT; Bradford CR; Chepeha DB; Eisbruch A
J Clin Oncol; 2010 Jun; 28(16):2732-8. PubMed ID: 20421546
[TBL] [Abstract][Full Text] [Related]
4. Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.
Vainshtein JM; Moon DH; Feng FY; Chepeha DB; Eisbruch A; Stenmark MH
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):925-33. PubMed ID: 25832685
[TBL] [Abstract][Full Text] [Related]
5. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes.
Hunter KU; Schipper M; Feng FY; Lyden T; Haxer M; Murdoch-Kinch CA; Cornwall B; Lee CS; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):935-40. PubMed ID: 23040224
[TBL] [Abstract][Full Text] [Related]
6. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?
Eisbruch A; Schwartz M; Rasch C; Vineberg K; Damen E; Van As CJ; Marsh R; Pameijer FA; Balm AJ
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1425-39. PubMed ID: 15590174
[TBL] [Abstract][Full Text] [Related]
7. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
Schwartz DL; Hutcheson K; Barringer D; Tucker SL; Kies M; Holsinger FC; Ang KK; Morrison WH; Rosenthal DI; Garden AS; Dong L; Lewin JS
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1356-65. PubMed ID: 20646872
[TBL] [Abstract][Full Text] [Related]
8. Sparing the larynx and esophageal inlet expedites feeding tube removal in patients with stage III-IV oropharyngeal squamous cell carcinoma treated with intensity-modulated radiotherapy.
Amin N; Reddy K; Westerly D; Raben D; DeWitt P; Chen C
Laryngoscope; 2012 Dec; 122(12):2736-42. PubMed ID: 22991101
[TBL] [Abstract][Full Text] [Related]
9. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences.
Eisbruch A; Levendag PC; Feng FY; Teguh D; Lyden T; Schmitz PI; Haxer M; Noever I; Chepeha DB; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S40-2. PubMed ID: 17848291
[TBL] [Abstract][Full Text] [Related]
10. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
Gensheimer MF; Nyflot M; Laramore GE; Liao JJ; Parvathaneni U
Radiat Oncol; 2016 Nov; 11(1):151. PubMed ID: 27846899
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry.
Kamal M; Mohamed ASR; Volpe S; Zaveri J; Barrow MP; Gunn GB; Lai SY; Ferrarotto R; Lewin JS; Rosenthal DI; Jethanandani A; Meheissen MAM; Mulder SL; Cardenas CE; Fuller CD; Hutcheson KA;
Radiother Oncol; 2018 Sep; 128(3):442-451. PubMed ID: 29961581
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Chera BS; Fried D; Price A; Amdur RJ; Mendenhall W; Lu C; Das S; Sheets N; Marks L; Mavroidis P
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1022-1027. PubMed ID: 28721884
[TBL] [Abstract][Full Text] [Related]
13. Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma.
Mogadas S; Busch CJ; Pflug C; Hanken H; Krüll A; Petersen C; Tribius S
Strahlenther Onkol; 2020 Jun; 196(6):522-529. PubMed ID: 32006068
[TBL] [Abstract][Full Text] [Related]
14. Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors.
Hunter KU; Lee OE; Lyden TH; Haxer MJ; Feng FY; Schipper M; Worden F; Prince ME; McLean SA; Wolf GT; Bradford CR; Chepeha DB; Eisbruch A
Head Neck; 2014 Jan; 36(1):120-5. PubMed ID: 23729173
[TBL] [Abstract][Full Text] [Related]
15. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.
Petkar I; Rooney K; Roe JW; Patterson JM; Bernstein D; Tyler JM; Emson MA; Morden JP; Mertens K; Miles E; Beasley M; Roques T; Bhide SA; Newbold KL; Harrington KJ; Hall E; Nutting CM
BMC Cancer; 2016 Oct; 16(1):770. PubMed ID: 27716125
[TBL] [Abstract][Full Text] [Related]
16. Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: is there a place for critical swallowing structures dose sparing?
Cilla S; Deodato F; Macchia G; Digesù C; Ianiro A; Piermattei A; Valentini V; Morganti AG
Br J Radiol; 2016; 89(1059):20150764. PubMed ID: 26728543
[TBL] [Abstract][Full Text] [Related]
17. A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial.
Joint Head and Neck Radiotherapy-MRI Development Cooperative
Radiother Oncol; 2019 Jan; 130():46-55. PubMed ID: 30206020
[TBL] [Abstract][Full Text] [Related]
18. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.
Little M; Schipper M; Feng FY; Vineberg K; Cornwall C; Murdoch-Kinch CA; Eisbruch A
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1007-14. PubMed ID: 22056067
[TBL] [Abstract][Full Text] [Related]
19. Tongue-out versus tongue-in position during intensity-modulated radiotherapy for base of tongue cancer: Clinical implications for minimizing post-radiotherapy swallowing dysfunction.
Kil WJ; Kulasekere C; Hatch C; Bugno J; Derrwaldt R
Head Neck; 2017 Aug; 39(8):E85-E91. PubMed ID: 28475284
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported voice and speech outcomes after whole-neck intensity modulated radiation therapy and chemotherapy for oropharyngeal cancer: prospective longitudinal study.
Vainshtein JM; Griffith KA; Feng FY; Vineberg KA; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):973-980. PubMed ID: 24803039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
